TY  - JOUR
T1  - PHarmaceutical fraud and abuse in the united states, 1996-2010
AU  - Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL
Y1  - 2011/09/12
N1  - 10.1001/archinternmed.2011.397
JO  - Archives of Internal Medicine
SP  - 1503
EP  - 1506
VL  - 171
IS  - 16
N2  - 
Prescription drug spending totaled $234 billion in 2008 (up from $40 billion in 1990) and accounted for 10% of health care expenditures.1 Pharmaceutical fraud may be an important component of health care costs. Between 1996 and 2005, $3.6 billion was recovered for 13 pharmaceutical fraud cases initiated by “whistle blowers” (termed qui tam relators). These recoveries, despite accounting for 3% of the number of federal fraud cases involving health care, accounted for 40% of federal fraud financial recoveries involving qui tam relators.2 We report on pharmaceutical fraud investigations completed between 1996 and 2010 regardless of qui tam relator involvement status.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.397
UR  - http://dx.doi.org/10.1001/archinternmed.2011.397
ER  -